FDA pharmacy and sports rules
How does Wolverine legal status affect your care?
FDA records for BPC-157 and the short TB-500 part of Thymosin Beta-4 have changed. Withdrawal isn’t approval, and it doesn’t promise pharmacy access for you.
Where do both parts of Wolverine stand now?
Are both Wolverine parts approved drugs? They aren’t, and the Wolverine mix has no FDA-approved use.
FDA once put BPC-157 and TB-500, including the short part copied from Thymosin Beta-4, in Category 2, its group for drug ingredients that raised serious safety concerns. That listing appeared in the September 29, 2023 update.
FDA’s page marked current on April 22, 2026 lists each request as withdrawn. Neither remains in Category 2, but withdrawal doesn’t approve a drug for you [14].
The next public step was an FDA adviser meeting set for July 23-24, 2026. The advisers were due to talk over letting pharmacies use either substance [16].
That meeting offered advice, not a final ruling. As of September 2026, the group’s votes were still missing from FDA’s site [16].
I’d ask a clinic which federal pharmacy rule lets it offer BPC-157 and TB-500 before discussing care. A date on an FDA page tells you when the page was current, not when FDA approved a drug.
What did FDA Category 2 mean for a pharmacy?
Why does a pharmacy need FDA's say-so at all? Under federal law, a pharmacy licensed by its state can mix a medicine for one patient, but only once a doctor has written a prescription naming that one person [15].
A second kind of pharmacy, one registered with FDA, makes bigger batches under tighter factory-style rules. Neither kind can turn an unapproved ingredient into an approved drug.
The catch is the raw ingredient. A pharmacy may start from one only if it's described in the official drug reference book, already sits inside an approved drug, or is on FDA's own list of allowed pharmacy ingredients [15].
Neither Wolverine part is an approved drug, so for them it comes down to that list. If an ingredient isn't on it, someone can ask FDA to add it, and the answer may take years or be no.
While it weighed those requests, FDA sorted them into Category 1 or Category 2. Category 1 meant a pharmacy could generally keep using the ingredient while FDA decided; Category 2 meant FDA saw serious safety risks and gave pharmacies no such leeway [15].
FDA said a pharmacy that mixed a drug from a Category 2 ingredient could face action from the agency. For both Wolverine parts it named three worries: your immune system might react to them, the drug could carry impurities, and it was hard to prove what the active ingredient really was [14].
Since January 7, 2025, FDA no longer sorts new requests into those two groups. Requests sorted before then keep their old group, and the safety-risk group still gets no leeway [15].
What happens before a pharmacy makes medicine for you?
What normally happens before a pharmacy makes your drug? A doctor, or a nurse practitioner or other licensed prescriber, examines you, goes over your health and your other medicines, and decides whether a made-to-order drug fits you and the law.
That prescriber writes a prescription for you alone. Your state-licensed pharmacy can then mix it, or an FDA-registered pharmacy may make it as part of a bigger batch [15].
Your first visit may happen by video. The prescriber still has to check you over and answer for your care [15].
The ingredient rule is the hard part. A pharmacy may use only a raw ingredient allowed under the federal rules for raw drug ingredients [15].
FDA's current page shows the BPC-157 and TB-500 requests withdrawn, but the agency hasn't spelled out what that means for pharmacies [14].
FDA also hadn’t posted the adviser votes as of September 17, 2026 [16]. Until it does, you can't count on getting the mix through a clinic or pharmacy.
At a visit, you can ask which rule permits the ingredient and which pharmacy would make it. The answer matters before you spend your money or your time.
What are the plain answers about Wolverine’s legal status?
Is Wolverine legal?
Wolverine has no FDA-approved use, and neither BPC-157 nor the small TB-500 part copied from Thymosin Beta-4 is approved. On September 29, 2023, FDA placed both in Category 2, its group for pharmacy ingredients with serious safety concerns [14].
FDA’s page dated April 22, 2026 shows the requests withdrawn and outside Category 2. FDA hasn’t said what pharmacies are now free to do, and withdrawal isn’t approval.
Can a pharmacy make BPC-157 for you?
FDA’s page current through April 22, 2026 shows BPC-157 outside Category 2 after whoever had asked FDA to allow it withdrew the request [14]. The safety concerns remain on the page, and FDA hasn’t given pharmacies a clear reading of the withdrawal.
A pharmacy making a drug for you still needs an allowed ingredient and a valid prescription from a doctor or another licensed prescriber. FDA hadn’t given a new answer under federal pharmacy rules after the July 2026 adviser meeting [15][16].
What is FDA’s current pharmacy status for Wolverine?
The mix has no FDA approval for any use. BPC-157 and the small TB-500 part copied from Thymosin Beta-4 entered Category 2 on September 29, 2023, but FDA’s page marked current on April 22, 2026 lists each request as withdrawn [14].
BPC-157 and the small part copied from Thymosin Beta-4 were set for review at the July 23-24, 2026 adviser meeting about which ingredients pharmacies may use. That was one step in a review, and FDA hasn’t posted the votes [16].
What do FDA approval and sports bans mean for BPC-157 and TB-500?
Neither substance has FDA approval for use in people. Sport bans both too, through the World Anti-Doping Agency, or WADA [14]. One WADA rule covers any drug not approved for people, and others cover TB-500 and substances that can change cell growth.
If you compete, ask your sports body how the rules apply to you and your case. A clinic visit won’t erase a drug-testing rule.